Device beats drugs for atrial fib

A Johnson & Johnson unit released study data yesterday showing that its catheter-based system might be more effective than drugs are at resolving heart arrhythmias. The company's Biosense Webster unit is hoping to gain FDA approval to market the device for the treatment of atrial fibrillation, making it the first approved device to treat the condition. AtriCure , Boston Scientific, Medtronic and St. Jude Medical all have competing devices, but none have received FDA approval for the condition to date. Report

 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.